EUVIMEDEUVIMED entdecken
Open Access

Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer

Heng-Min Xu, Yuting Han, Zong-Chao Liu, Zhou-Yi Yin, Meng-Yuan Wang, Canqing Yu, Jun-Ling Ma, Dianjianyi Sun, Wei-Dong Liu, Yang Zhang, Tong Zhou, Jing-Ying Zhang und 12 weitere

JAMA Network Open · 29.05.2024 · 7 (5) · e2413708

DOI: 10.1001/jamanetworkopen.2024.13708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 29.05.2024. Verfasst von Heng-Min Xu und 23 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Resea…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections, Genetic Predisposition to Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Helicobacter pylori treatment and nutrition supplementation may protect against gastric cancer (GC), but whether the beneficial effects only apply to potential genetic subgroups and whether high genetic risk may be counteracted by these chemoprevention strategies remains unknown.

Objective

To examine genetic variants associated with the progression of gastric lesions and GC risk and to assess the benefits of H pylori treatment and nutrition supplementation by levels of genetic risk. Design, Setting, and Participants This cohort study used follow-up data of the Shandong Intervention Trial (SIT, 1989-2022) and China Kadoorie Biobank (CKB, 2004-2018) in China. Based on the SIT, a longitudinal genome-wide association study was conducted to identify genetic variants for gastric lesion progression. Significant variants were examined for incident GC in a randomly sampled set of CKB participants (set 1). Polygenic risk scores (PRSs) combining independent variants were assessed for GC risk in the remaining CKB participants (set 2) and in an independent case-control study in Linqu. Exposures H pylori treatment and nutrition supplementation. Main Outcomes and Measures Primary outcomes were the progression of gastric lesions (in SIT only) and the risk of GC. The associations of H pylori treatment and nutrition supplementation with GC were evaluated among SIT participants with different levels of genetic risk.

Results

Our analyses included 2816 participants (mean [SD] age, 46.95 [9.12] years; 1429 [50.75%] women) in SIT and 100 228 participants (mean [SD] age, 53.69 [11.00] years; 57 357 [57.23%] women) in CKB, with 147 GC cases in SIT and 825 GC cases in CKB identified during follow-up. A PRS integrating 12 genomic loci associated with gastric lesion progression and incident GC risk was derived, which was associated with GC risk in CKB (highest vs lowest decile of PRS: hazard ratio [HR], 2.54; 95% CI, 1.80-3.57) and further validated in the analysis of 702 case participants and 692 control participants (mean [SD] age, 54.54 [7.66] years; 527 [37.80%] women; odds ratio, 1.83; 95% CI, 1.11-3.05). H pylori treatment was associated with reduced GC risk only for individuals with high genetic risk (top 25% of PRS: HR, 0.45; 95% CI, 0.24-0.82) but not for those with low genetic risk (HR, 0.81; 95% CI, 0.50-1.34; P for interaction = .03). Such effect modification was not found for vitamin ( P for interaction = .93) or garlic ( P for interaction = .41) supplementation. Conclusions and Relevance The findings of this cohort study indicate that a high genetic risk of GC may be counteracted by H pylori treatment, suggesting primary prevention could be tailored to genetic risk for more effective prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHelicobacter pyloriHelicobacter InfectionsGenetic Predisposition to DiseaseHumansFemaleMaleMiddle AgedChinaGenome-Wide Association StudyCase-Control StudiesAdultRisk FactorsDietary SupplementsCohort StudiesAgedAnti-Bacterial Agents

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Cancer Epidemiology, Peking University Cancer Hospi…
  • Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.
  • Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.
  • Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
  • Linqu Public Health Bureau, Linqu, Shandong, China.

Förderung

  • Wellcome Trust
  • NCI NIH HHS

Zitieren

APA

Xu, H. M., Han, Y., Liu, Z. C., Yin, Z. Y., Wang, M. Y., Yu, C., Ma, J. L., Sun, D., Liu, W. D., Zhang, Y., Zhou, T., Zhang, J. Y., Pei, P., Yang, L., Millwood, I. Y., Walters, R. G., Chen, Y., Du, H., Chen, Z., …, & Li, W. Q. (2024). Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer. JAMA Network Open, 7(5), e2413708. https://doi.org/10.1001/jamanetworkopen.2024.13708

Vancouver

Xu HM, Han Y, Liu ZC, Yin ZY, Wang MY, Yu C, et al. Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer. JAMA Network Open. 2024;7(5):e2413708. doi:10.1001/jamanetworkopen.2024.13708

BibTeX
@article{Xu2024,
  author = {Xu, Heng-Min and Han, Yuting and Liu, Zong-Chao and Yin, Zhou-Yi and Wang, Meng-Yuan and Yu, Canqing and Ma, Jun-Ling and Sun, Dianjianyi and Liu, Wei-Dong and Zhang, Yang and Zhou, Tong and Zhang, Jing-Ying and Pei, Pei and Yang, Ling and Millwood, Iona Y and Walters, Robin G and Chen, Yiping and Du, Huaidong and Chen, Zhengming and You, Wei-Cheng and Li, Liming and Pan, Kai-Feng and Lv, Jun and Li, Wen-Qing},
  title = {Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {5},
  pages = {e2413708},
  doi = {10.1001/jamanetworkopen.2024.13708}
}
Kostenlos starten →